Search
The transition of Value Research Online has been postponed to take care of some user concerns.
You are welcome to try out the new site at https://beta.valueresearchonline.com

Nippon India Pharma Fund - Direct Plan Unrated

Value Research
-0.69%
Change from previous, NAV as on Dec 05, 2019
Category: Equity: Sectoral-Pharma
Assets: R 2,430 crore (As on Oct 31, 2019)
Expense: 1.36% (As on Oct 31, 2019)
SUBSCRIBE TO THE VALUE RESEARCH FUNDLINE NEWSLETTER
SIP Returns
Amount
Frequency
Start Date
End Date


Please wait while we are fetching data...
Choose the best mutual funds
Reach all your financial goals. Subscribe to Mutual Fund Insight now!
Basic Details
Fund House: Nippon India Mutual Fund
Launch Date: Jan 01, 2013
Benchmark: S&P BSE Healthcare TRI
Riskometer: High
Risk Grade: -
Return Grade: -
Turnover: 19%
Type: Open-ended
Investment Details
Return since Launch: 12.72%
Minimum Investment (R) 5,000
Minimum Addl Investment (R) 1,000
Minimum SIP Investment (R) 500
Minimum No of Cheques 36
Minimum Withdrawal (R) 100
Minimum Balance (R) 1
Exit Load (%) 1% for redemption within 365 days
Performance
  YTD 1-Month 3-Month 1-Year 3-Year 5-Year 10-Year
Fund 1.90 2.06 6.40 1.53 2.90 4.63 -
S&P BSE Healthcare TRI -2.49 2.19 4.39 -2.15 -4.30 -1.45 -
Category 4.68 2.30 6.27 4.98 -0.07 2.16 -
Rank within Category 5 8 5 6 1 1 -
Number of funds in category 7 9 9 7 4 3 0
As on Dec 05, 2019
Peer Comparison
Fund Rating Launch 1-Year Ret 3-Year Ret 5-Year Ret Expense Ratio (%) Assets
(Cr)
Nippon India Pharma Fund - Direct Plan Unrated Jan-2013 1.53 2.90 4.63 1.36 2,430
Mirae Asset Healthcare Fund - Direct Plan Unrated Jul-2018 7.37 - - 0.79 358
SBI Healthcare Opportunities Fund - Direct Plan Unrated Jan-2013 0.21 -3.73 1.06 1.33 937
Tata India Pharma & HealthCare Fund - Direct Plan Unrated Dec-2015 8.14 2.06 - 1.16 174
UTI Healthcare Fund - Direct Plan Unrated Jan-2013 2.14 -1.50 0.78 1.76 393
Portfolio
Portfolio Aggregates
  Fund Benchmark* Category
Average Mkt Cap (Rs Cr) 25,589.10 - 23,291.84
Giant (%) - - 2.86
Large (%) 38.17 - 36.39
Mid (%) 52.51 - 51.76
Small (%) 9.32 - 11.53
Tiny (%) - - -
  Value Research Fund Style
 
Top Holdings
  Company Sector PE 3Y High 3Y Low % Assets
  Sun Pharmaceutical Inds. Healthcare 24.20 12.32 7.27 11.60
  Divi's Laboratories Healthcare 37.10 11.76 6.72 10.11
  Cipla Healthcare 22.59 11.10 5.81 9.03
  Dr. Reddy's Lab Healthcare 17.41 10.96 5.71 7.45
  Abbott India Healthcare 51.68 11.05 4.82 7.12
  Lupin Healthcare 112.50 9.44 3.33 7.05
  Fortis Healthcare (India) Healthcare 88.74 6.89 0.00 6.89
  Syngene International Healthcare 31.65 7.15 0.00 6.64
  Aurobindo Pharma Healthcare 10.23 10.31 5.74 5.74
  Alkem Laboratories Healthcare 27.03 5.55 0.00 5.55
   Indicates an increase or decrease or no change in holding since last portfolio
 Indicates a new holding since last portfolio
As on Oct 31, 2019
Most Recent Dividends
  Plan Record Date Dividend
(R / Unit)
   
+ Dividend Mar 05, 2019 4.4270   More...
    Mar 05, 2018 6.0000    
    Mar 06, 2017 6.5000    
    Mar 04, 2016 7.0000    
    Jan 30, 2015 7.0000    
    Feb 14, 2014 4.5000    
News and Analysis
Contact Information

AMC: Nippon India Life Asset Management Ltd.

Address: Reliance Centre, 7th Floor, South Wing Off Western Express Highway Santacruz (East) Mumbai - 400055 | Phone: 022-68334800 / 18602660111 | Fax: 022-33037662

Email: [email protected]

Website: http://www.nipponindiamf.com



Registrar & Transfer Agent: Karvy Fintech Pvt Ltd.

Address: Karvy House, No. 46, 8-2-609/K, Avenue 4, Street No.1 Banjara Hills, Hyderabad - 500034 | Phone: 040-23312454

Email: [email protected]

Website: www.karvymfs.com